ADJUVANT CHEMOTHERAPY
Clinical trials for ADJUVANT CHEMOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new ADJUVANT CHEMOTHERAPY trials appear
Sign up with your email to follow new studies for ADJUVANT CHEMOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to wipe out hidden cancer cells after chemo
Disease control OngoingThis study tests whether two drugs, fruquintinib and tislelizumab, can control leftover cancer cells in people with colorectal cancer who have completed chemotherapy but still show signs of minimal residual disease (MRD) on a blood test. About 20 adults with stable disease will r…
Matched conditions: ADJUVANT CHEMOTHERAPY
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New combo therapy aims to stop lung cancer return after surgery
Disease control OngoingThis Phase III trial tests whether adding immunotherapy to standard chemotherapy after lung cancer surgery can delay or prevent the cancer from coming back. It enrolls 210 patients with stage IB-IIIA non-small cell lung cancer that was completely removed. Participants are randoml…
Matched conditions: ADJUVANT CHEMOTHERAPY
Phase: PHASE3 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC